29 companies

Johnson & Johnson

Market Cap: US$574.4b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

JNJ

US$238.46

7D

-1.9%

1Y

57.2%

Roche Holding

Market Cap: CHF 252.5b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

ROP

CHF 315.60

7D

-0.8%

1Y

29.5%

Merck

Market Cap: US$299.9b

Operates as a healthcare company worldwide.

MRK

US$121.42

7D

0.5%

1Y

53.3%

Gilead Sciences

Market Cap: US$172.6b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

GILD

US$138.99

7D

-0.5%

1Y

34.1%

Sanofi

Market Cap: €96.8b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

SAN

€80.19

7D

-2.9%

1Y

-10.5%

CSL

Market Cap: AU$66.8b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

CSL

AU$139.19

7D

0.2%

1Y

-40.3%

Daiichi Sankyo Company

Market Cap: JP¥5.1t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

4568

JP¥2,772.50

7D

-3.2%

1Y

-10.7%

Astellas Pharma

Market Cap: JP¥4.7t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

4503

JP¥2,607.00

7D

0.8%

1Y

105.4%

Yunnan Baiyao GroupLtd

Market Cap: CN¥98.0b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥54.92

7D

-2.7%

1Y

-3.4%

CSPC Pharmaceutical Group

Market Cap: HK$105.9b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093

HK$9.26

7D

-4.6%

1Y

75.7%

Orion Oyj

Market Cap: €10.3b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€73.10

7D

2.0%

1Y

52.5%

Qiagen

Market Cap: US$8.5b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

QGEN

US$40.89

7D

-0.3%

1Y

-7.5%

Gedeon Richter

Market Cap: Ft2.3t

Researches, develops, manufactures, markets, and sells pharmaceutical products.

RICHTER

Ft12,800.00

7D

5.3%

1Y

25.0%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥46.3b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥27.80

7D

-1.2%

1Y

-18.1%

H. Lundbeck

Market Cap: DKK 38.8b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

HLUN B

DKK 40.38

7D

-1.0%

1Y

44.2%

Beijing Tongrentang

Market Cap: CN¥38.1b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

600085

CN¥27.80

7D

-0.1%

1Y

-24.3%

Dong-E-E-Jiao

Market Cap: CN¥35.2b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

000423

CN¥54.76

7D

-2.4%

1Y

-11.1%

Livzon Pharmaceutical Group

Market Cap: CN¥27.8b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

000513

CN¥34.39

7D

-0.1%

1Y

0.6%

Hikma Pharmaceuticals

Market Cap: UK£2.9b

Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.

HIK

UK£13.22

7D

1.1%

1Y

-27.8%

Dermapharm Holding

Market Cap: €2.4b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

New

DMP

€43.95

7D

-7.0%

1Y

20.2%

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥15.3b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

603456

CN¥17.34

7D

1.7%

1Y

38.2%

Tecan Group

Market Cap: CHF 1.7b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

TECN

CHF 134.90

7D

-0.4%

1Y

-6.3%

Faes Farma

Market Cap: €1.5b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.

FAE

€4.90

7D

4.3%

1Y

32.1%

Tsumura

Market Cap: JP¥281.7b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

New

4540

JP¥3,779.00

7D

-1.7%

1Y

-7.1%

Kissei Pharmaceutical

Market Cap: JP¥194.8b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

4547

JP¥4,700.00

7D

-2.6%

1Y

32.8%

Wuhan Keqian BiologyLtd

Market Cap: CN¥7.0b

Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.

688526

CN¥15.05

7D

2.8%

1Y

-6.0%

Mega Lifesciences

Market Cap: ฿29.9b

Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods.

MEGA

฿34.25

7D

3.0%

1Y

24.5%

ChemoMetec

Market Cap: DKK 5.3b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

CHEMM

DKK 303.40

7D

-1.8%

1Y

-33.8%

Duopharma Biotech Berhad

Market Cap: RM 1.3b

An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.32

7D

3.1%

1Y

13.8%